Register entry
Harrow Eye, LLC
- Registered sites
- 0
- Drug products
- 17
- Live patents
- 28
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
28Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| BYQLOVI | CLOBETASOL PROPIONATE | May 2036 |
| IHEEZO | CHLOROPROCAINE HYDROCHLORIDE | Sept 2038 |
| IHEEZO | CHLOROPROCAINE HYDROCHLORIDE | May 2039 |
| ILEVRO | NEPAFENAC | Dec 2030 |
| ILEVRO | NEPAFENAC | Mar 2032 |
| MOXEZA | MOXIFLOXACIN HYDROCHLORIDE | May 2029 |
| NEVANAC | NEPAFENAC | Jan 2027 |
| TOBRADEX ST | DEXAMETHASONE; TOBRAMYCIN | Dec 2027 |
| TOBRADEX ST | DEXAMETHASONE; TOBRAMYCIN | Aug 2028 |
| TRIESENCE | TRIAMCINOLONE ACETONIDE | Mar 2029 |
| TRIESENCE | TRIAMCINOLONE ACETONIDE | Dec 2029 |
| VERKAZIA | CYCLOSPORINE | Nov 2027 |
| VERKAZIA | CYCLOSPORINE | Jun 2029 |
| VEVYE | CYCLOSPORINE | Dec 2030 |
| VEVYE | CYCLOSPORINE | Sept 2036 |
| VEVYE | CYCLOSPORINE | Sept 2037 |
| VEVYE | CYCLOSPORINE | Nov 2038 |
| VEVYE | CYCLOSPORINE | Oct 2039 |
| VEVYE | CYCLOSPORINE | Apr 2042 |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | Mar 2030 |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | Sept 2030 |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | Jul 2032 |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | Jan 2033 |
Catalogue
Marketed products
17Showing 17 of 17.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| BYQLOVI | clobetasol propionate | FOR SUSPENSION | NDA |
| Byooviz | ranibizumab-nuna | INJECTION, SOLUTION | BLA |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | povidone, polyvinyl alcohol solution | SOLUTION/ DROPS | OTC MONOGRAPH DRUG |
| Flarex | fluorometholone acetate | SUSPENSION/ DROPS | NDA |
| IHEEZO | chloroprocaine hydrochloride ophthalmic gel | GEL | NDA |
| ILEVRO | nepafenac | SUSPENSION/ DROPS | NDA |
| IOPIDINE 1% | apraclonidine hydrochloride ophthalmic solution | SOLUTION/ DROPS | NDA |
| MAXIDEX | dexamethasone | FOR SUSPENSION | NDA |
| Maxitrol | neomycin sulfate, polymyxin b sulfate and dexamethasone | SUSPENSION | NDA |
| NATACYN | natamycin | SUSPENSION/ DROPS | NDA |
| NEVANAC | nepafenac | SUSPENSION/ DROPS | NDA |
| TRIESENCE | triamcinolone acetonide | INJECTION, SUSPENSION | NDA |
| Tobradex ST | tobramycin / dexamethasone | SUSPENSION/ DROPS | NDA |
| VEVYE | cyclosporine ophthalmic solution | SOLUTION/ DROPS | NDA |
| VIGAMOX | moxifloxacin hydrochloride | SOLUTION/ DROPS | NDA |
| Verkazia | cyclosporine | EMULSION | NDA |
| ZERVIATE | cetirizine | FOR SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.